Zoha Majeed, MD
@zohamajeed
Followers
757
Following
3K
Media
15
Statuses
454
Internal Medicine PGY 3 @clevelandclinic • behind the 🎙️ on #MedicineGrandRounders podcast • #WIM #MedEd
Cleveland, OH
Joined March 2012
Our latest article is now published in @JACCJournals 35% of referred pericarditis cases were misdiagnosed, highlighting the value of LGE-MRI and inflammatory markers Grateful to share my work back with @CCF_IMCHIEFS @AllanLKleinMD1 @CleClinicHVTI
https://t.co/n3fD6PAoti
8
9
52
🔥 New in @NatureMedicine How do you communicate lifetime benefits expected with HFpEF therapies? New data from 3 RCTs (#DELIVER #FINEARTS #PARAGON) estimate up to *5 years* of event-free survival w combination Rx #GDMT for HFpEF has finally arrived! 🔗 https://t.co/ozSx3UwkLN
6
143
339
Here’s a 6-point nuanced update from the 2025 ESC/EAS Dyslipidaemia Guidelines #ESCCongress 1.Risk Refinement with Imaging: #yesCCT #CVimaging CAC scoring and subclinical atherosclerosis imaging are upgraded to Class IIa, Level B for refining risk in moderate-risk patients or
4
112
289
Also 30-40% weight loss is muscle, but this entails losing intramuscular fat. So the muscle mass is actually leaner and of much better quality. Paired with weight lifting, 1g/kg/day of protein intake and cardio (at least 80% of max HR) it preserves muscle and ⬆️ metabolic rate.
Why does Zepbound (tirzepatide) lead to more weight loss than Ozempic (semaglutide)? The dual receptor (GLP-1+ GIP) has more pronounced effects in the brain https://t.co/1aLDifDS2o
0
1
0
On this Ep🎤 #MedicineGrandRounders 🎙️ with Dr Bret Lashner (IBD specialist) and #AnthonyGallo on IBD Essentials 💩💊 Website🔗 https://t.co/L0wMEugjQR Spotify🎤 https://t.co/uirgnYmm7d Apple🎵 https://t.co/7J018f5AJP
#MedEd @AndreiBrateanu @zohamajeed @NituKataria
0
10
36
What a unique opportunity to create a PODCAST with one of my mentors @dangeliniMD on the topic of anticoagulation! 💉🩸 Thank you #MedicineGrandRounders Team! @AndreiBrateanu @Chatterjee_MD @SouaidTarek @zohamajeed @NituKataria @CCF_IMCHIEFS & SharonLee
1
3
15
0
2
7
#MedicineGrandRounders Ep#20 🎙️with @CleClinicHVTI Heart Failure Cardiologist @SBhattacharyaMD and Yasmine El Ghoul on HFpEF. 🫀 Website: https://t.co/hOs3NiS5Lp Apple: https://t.co/N3fwVXq0Br Spotify:
podcasts.apple.com
Podcast Episode · The Medicine Grand Rounders · 06/23/2025 · 18m
1
3
24
Dr. Aroda presents at #ASPC2025 on GLP-1RA & Outcomes 🫀the evolution of the discovery & effectiveness of therapies 🫀our meta analysis showed the effectiveness @FredRiveraMD ⭐️ 🫀ADA now puts cardiometabolic phenotype dictates tx
2
7
26
Lucky to have the opportunity to learn from such a fantastic clinician and educator!
Appreciate everyone who has been a part of this wonderful journey so far! Excited to collaborate with my colleagues to elevate our already phenomenal Dept of Hospital Medicine! @ClevelandClinic #PrabMD @RaedDweikMD @RSreedharan81 @whinnec @medpedshosp @OhioAcp
0
2
4
There's a lot more to magnesium than just a lab test we routinely check and attempt to normalize. This paper examines the mechanisms by which magnesium is related to PNA, COPD, asthma, and ACS. 🎩 tip to the authors. https://t.co/Sfr6vCn6le
0
21
99
feat. the best team: @SouaidTarek @Chatterjee_MD @AndreiBrateanu @NituKataria #SharonLee @CCF_IMCHIEFS
0
0
3
#MedicineGrandRounders Ep#19🎙️ with @ClevelandClinic haematologist @dangeliniMD and @CleClinCLM @CaseSOM MS3 🌟 @SeyshaMehta on the do’s and don’ts of anticoagulation! 🩸 Website: https://t.co/oo18Qrm75h Spotify: https://t.co/M8pcquHWkT Apple:
podcasts.apple.com
Podcast Episode · The Medicine Grand Rounders · 05/26/2025 · 20m
1
4
16
Grateful to get to work with the fantastic students at @ClevelandClinic Lerner College of Medicine! Truly an honour. @craigniel13 @Neil_Mehta @AndreiBrateanu @MoMohmandMD
3
0
88
Efficacy of CAR T for treatment of AL Amyloidosis, a case series We now have a BCMA CAR T phase I trial open at Cleveland Clinic for Amyloidosis https://t.co/DVfR3k5TDm
onlinelibrary.wiley.com
Clinical trials evaluating chimeric antigen receptor (CAR) T-cell therapy in relapsed/refractory multiple myeloma (RRMM) have typically excluded patients with AL amyloidosis. As a result, there are...
0
4
24
Outstanding presentation @zohamajeed on adding malignancy to CHADsVASC score in cancer patient .@DrRohitMoudgil congratulations on your mentorship @CCF_IMCHIEFS @tavrkapadia @LarsSvenssonMD @CleClinicHVTI
1
3
39
@zohamajeed representing @CCF_IMCHIEFS at the @ClevelandClinic medicine grand rounds! @AndreiBrateanu
1
2
20
Congratulations to my friend and colleague, @AshishSarraju , and the team at C5Research (@CleClinicHVTI ) on completing and publishing the TANDEM trial demonstrating the lipid lowering efficacy of obicetrapib-ezetimibe FDC
1
5
35